These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34043784)

  • 1. Risk Factors for Death Among the First 80 543 Coronavirus Disease 2019 (COVID-19) Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region.
    Zhang Y; Luo W; Li Q; Wang X; Chen J; Song Q; Tu H; Ren R; Li C; Li D; Zhao J; McGoogan JM; Shan D; Li B; Zhang J; Dong Y; Jin Y; Mao S; Qian M; Lv C; Zhu H; Wang L; Xiao L; Xu J; Yin D; Zhou L; Li Z; Shi G; Dong X; Guan X; Gao GF; Wu Z; Feng Z
    Clin Infect Dis; 2022 Mar; 74(4):630-638. PubMed ID: 34043784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.
    Mizumoto K; Chowell G
    Emerg Infect Dis; 2020 Jun; 26(6):1251-1256. PubMed ID: 32168464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the instant case fatality rate of COVID-19 in China.
    Mi YN; Huang TT; Zhang JX; Qin Q; Gong YX; Liu SY; Xue HM; Ning CH; Cao L; Cao YX
    Int J Infect Dis; 2020 Aug; 97():1-6. PubMed ID: 32339723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.
    Liang WH; Guan WJ; Li CC; Li YM; Liang HR; Zhao Y; Liu XQ; Sang L; Chen RC; Tang CL; Wang T; Wang W; He QH; Chen ZS; Wong SS; Zanin M; Liu J; Xu X; Huang J; Li JF; Ou LM; Cheng B; Xiong S; Xie ZH; Ni ZY; Hu Y; Liu L; Shan H; Lei CL; Peng YX; Wei L; Liu Y; Hu YH; Peng P; Wang JM; Liu JY; Chen Z; Li G; Zheng ZJ; Qiu SQ; Luo J; Ye CJ; Zhu SY; Cheng LL; Ye F; Li SY; Zheng JP; Zhang NF; Zhong NS; He JX
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32269086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Fatality Risk of the First Pandemic Wave of Coronavirus Disease 2019 (COVID-19) in China.
    Deng X; Yang J; Wang W; Wang X; Zhou J; Chen Z; Li J; Chen Y; Yan H; Zhang J; Zhang Y; Wang Y; Qiu Q; Gong H; Wei X; Wang L; Sun K; Wu P; Ajelli M; Cowling BJ; Viboud C; Yu H
    Clin Infect Dis; 2021 Jul; 73(1):e79-e85. PubMed ID: 32409826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
    PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis.
    Lu QB; Zhang HY; Che TL; Zhao H; Chen X; Li R; Jiang WL; Zeng HL; Zhang XA; Long H; Wang Q; Wu MQ; Ward MP; Chen Y; Zhang ZJ; Yang Y; Fang LQ; Liu W
    BMC Infect Dis; 2021 May; 21(1):481. PubMed ID: 34039295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent Gender Differences in COVID-19 in Mainland China: Comparative Study.
    Qian J; Zhao L; Ye RZ; Li XJ; Liu YL
    Clin Infect Dis; 2020 Dec; 71(9):2488-2494. PubMed ID: 32473009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of COVID-19 and SARS in mainland China: a comparative study based on national surveillance data.
    Zhao L; Feng D; Ye RZ; Wang HT; Zhou YH; Wei JT; de Vlas SJ; Cui XM; Jia N; Yin CN; Li SX; Wang ZQ; Cao WC
    BMJ Open; 2020 Oct; 10(10):e043411. PubMed ID: 33060093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data-based analysis, modelling and forecasting of the COVID-19 outbreak.
    Anastassopoulou C; Russo L; Tsakris A; Siettos C
    PLoS One; 2020; 15(3):e0230405. PubMed ID: 32231374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of particulate matter pollution and case fatality rate of COVID-19 in 49 Chinese cities.
    Yao Y; Pan J; Wang W; Liu Z; Kan H; Qiu Y; Meng X; Wang W
    Sci Total Environ; 2020 Nov; 741():140396. PubMed ID: 32592974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].
    Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Feb; 41(2):145-151. PubMed ID: 32064853
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China.
    Kim S; Choi S; Ko Y; Ki M; Jung E
    Theor Biol Med Model; 2020 Jun; 17(1):9. PubMed ID: 32498721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and Genomic Analysis of SARS-CoV-2 in 10 Patients From a Mid-Sized City Outside of Hubei, China in the Early Phase of the COVID-19 Outbreak.
    Chen J; Hilt EE; Li F; Wu H; Jiang Z; Zhang Q; Wang J; Wang Y; Li Z; Tang J; Yang S
    Front Public Health; 2020; 8():567621. PubMed ID: 33072702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Geography of COVID-19 Case Fatality Rates in China: A Spatial Autoregressive Probit-Log Linear Hurdle Analysis.
    Yu H; Lao X; Gu H; Zhao Z; He H
    Front Public Health; 2022; 10():751768. PubMed ID: 35242729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and clinical characteristics of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers in Hubei Province, China.
    Wu M; Xie C; Wu R; Shu Y; Wang L; Li M; Wang Y
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):924-930. PubMed ID: 33203485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the clinical characteristics and outcomes of COVID-19 patients in the epicenter and peripheral areas of the pandemic from China: a retrospective, large-sample, comparative analysis.
    Wang G; Luo FM; Liu D; Liu JS; Wang Y; Chen H; Tian PW; Fan T; Tang L; Yu H; Wang L; Feng M; Ni Z; Wang B; Song ZF; Wu XL; Wang HJ; Tong X; Xue M; Lei XY; Long B; Jia C; Xiao J; Shang J; Xiong N; Luo JF; Liang ZA; Li WM;
    BMC Infect Dis; 2021 Feb; 21(1):206. PubMed ID: 33627072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study.
    Lui GC; Yip TC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Chan HL; Hui DS; Wong GL
    Clin Infect Dis; 2021 May; 72(10):e466-e475. PubMed ID: 33005933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020.
    Kim SW; Kim SM; Kim YK; Kim JY; Lee YM; Kim BO; Hwangbo S; Park T
    J Korean Med Sci; 2021 Jan; 36(1):e12. PubMed ID: 33398946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
    Shi Q; Zhang X; Jiang F; Zhang X; Hu N; Bimu C; Feng J; Yan S; Guan Y; Xu D; He G; Chen C; Xiong X; Liu L; Li H; Tao J; Peng Z; Wang W
    Diabetes Care; 2020 Jul; 43(7):1382-1391. PubMed ID: 32409504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.